3.1. TMP ameliorated LPS-driven lung injury in vivo
We investigated the pathological changes in lung specimens, lung injury scores, and the W/D ratio in each group to confirm the impact of TMP on LPS-induced ALI. Preliminary observation of lung specimens in the LPS group revealed noticeable pathological alterations, thickening of alveolar walls, pulmonary edema, severe infiltration of leukocytes, and hemorrhage, which were all significantly ameliorated in TMP-pretreated mice. (Figure 1A) Two blinded pathologists assessed the lung injury scores. Using the semiquantitative system of lung injury scoring, we obtained unanimous results. The lung injury score was considerably higher in the LPS group than in the control group; however, TMP pretreatment dramatically decreased this score (P < 0.05). (Figure 1B) Noncardiogenic pulmonary edema was assessed using the lung W/D ratio. The W/D ratio was significantly higher in the LPS group than in the control group, and the W/D ratio was significantly lower in the LPS + TMP group than in the LPS group (P < 0.05). (Figure 1C)
To investigate the substantial therapeutic impact of TMP on endotoxin-induced ALI, we measured the serum levels of proinflammatory cytokines IL-1β, IL-6, and TNF-1α. As shown in Figure 1D-1F, exposure to LPS caused an apparent increase in IL-1β, IL-6, and TNF-α levels in mice, and TMP administration dramatically reduced these inflammatory factors (P < 0.05). Therefore, we conclude that TMP ameliorates LPS-induced pulmonary pathological damage and inflammatory responses in mice. No significant difference was noted between the TMP and control groups (P > 0.05).
3.2. TMP ameliorated apoptosis and oxidative stress in mice with LPS-induced ALI
We used TUNEL staining to assess apoptosis in lung tissues. (Figure 2A) The quantity of TUNEL-positive cells was substantially lower in the control and LPS + TMP groups than in the LPS group (P < 0.05). Thus, LPS stimulation exacerbated apoptosis in the lung tissue, which could be mitigated by TMP pretreatment.
The serum levels of GSH and GSSG and the GSH/GSSG ratio are the most common indicators of the response to oxidative damage. GSH levels and the GSH/GSSG ratio in lung tissues were lower, whereas GSSG levels were higher in the LPS group than in the control group (P < 0.05). (Figure 2B-2D) Compared with LPS, TMP preconditioning markedly increased GSH levels and the GSH/GSSG ratio and decreased GSSG levels in the lung tissue (P < 0.05). Thus, TMP decreased apoptosis and oxidative stress in mice exposed to LPS. In addition, the experimental results of the TMP group did not differ substantially from those of the control group (P > 0.05).
3.3. TMP alleviated Golgi stress and activated the Nrf2/HO-1 signaling pathway following LPS stimulation in vivo
Double immunofluorescence (IF) using GM130 antibody (FITC-labeling, red) and DAPI (nuclear staining, blue) was used to explore morphological changes in GA. Compared with the control group, the red fluorescence in the LPS group became weaker and more diffuse, whereas TMP pretreatment alleviated this change. (Figure 3A) Then, we evaluated GM130, Golgin97, ATP2C1, and GOLPH3 protein expression using western blotting to evaluate the level of Golgi stress. Figure 3B-F shows that compared with the control group, LPS treatment downregulated GM130, Golgin97, and ATP2C1 protein expression and upregulated GOLPH3 protein expression (P < 0.05). Nevertheless, TMP pretreatment partially attenuated this effect (P < 0.05). The results showed that TMP pretreatment might ameliorate LPS-induced Golgi stress exacerbated by LPS. TMP without LPS stimulation had no impact on these variables compared with the control group (P > 0.05).
To further explore whether TMP ameliorates endotoxin-induced ALI and Golgi stress via the Nrf2/HO-1 pathway, we assessed Nrf2 and HO-1 protein expression. TMP pretreatment significantly upregulated Nrf2 and HO-1 expression compared with those in the LPS group (P < 0.05). (Figure 3B, 3G, 3H) Thus, we surmised that the preventive benefits of TMP against endotoxin-induced ALI may be mediated via the Nrf2/HO-1 pathway.
3.4. Nrf2 KO partially offsets the protective effects of TMP induced by LPS on mice
Nrf2 KO mice were treated with or without LPS or TMP using the same method as that used for wild-type mice. Nrf2 KO + LPS mice showed more severe lung histopathological injury, increased inflammatory response, and greater oxidative damage than WT + LPS mice (P < 0.05). These results validated the role of Nrf2 as a protective regulator against endotoxin-induced ALI.
To further elucidate whether TMP acts as a lung-protective factor via the Nrf2/HO-1 pathway, we compared the Nrf2 KO + LPS + TMP group with the WT + LPS + TMP group. Thickened alveolar walls, alveolar hemorrhage, and neutrophil infiltration were more severe in the Nrf2 KO + LPS + TMP group than in the WT + LPS + TMP group. (Figure 4A) The lung injury scores and W/D ratio were significantly higher in the Nrf2 KO + LPS + TMP group than in the WT + LPS + TMP group (P < 0.05). (Figure 4B-4C) Moreover, IL-1β, IL-6, and TNF-α levels were increased by 2.45, 3.86, and 2.17 times, respectively, in the Nrf2 KO + LPS + TMP group compared with the WT + LPS + MP group (P < 0.05). (Figure 4D–4F) The oxidative stress indicators GSH level and the GSH/GSSG ratio were significantly lower in the Nrf2 KO + PS + TMP group than in the WT + LPS + TMP group (P < 0.05). (Figure 4G-4I) We conclude that Nrf2 KO partially counteracted the protective effect of TMP towards endotoxin-induced ALI. Specifically, TMP attenuates endotoxin-induced ALI via the Nrf2 pathway.
3.5. Nrf2 KO mice were used to identify TMP-mediated lung protection by alleviating Golgi stress via the Nrf2/HO-1 signaling pathway
To investigate the effect of the Nrf2 pathway on TMP pretreatment to attenuate Golgi stress, we used double IF with GM130 antibody and DAPI. Compared with WT + LPS + TMP mice, we observed decreased fluorescence intensity of FITC-GM130 in the Nrf2 KO + LPS + TMP group. (Figure 5A)
The protein content of Golgi stress-related proteins GM130, Golgin97, ATP2C1, and GOLPH3 was evaluated using western blotting. Compared with the WT + LPS group, the Nrf2 KO + LPS group had decreased GM130, Golgin97, and ATP2C1 levels and increased GOLPH3 levels, suggesting that Nrf2 KO aggravated LPS-induced Golgi stress (P < 0.05). (Figure 5B-5F) Compared with WT + LPS + TMP mice, Nrf2KO + LPS + TMP mice showed a more remarkable decrease in the protein content of GM130, Golgin97, and ATP2C1 and increased content of GOLPH3. Specifically, the alleviation of Golgi stress by TMP in LPS-stimulated ALI was partially offset by Nrf2 knockdown (P < 0.05). Nrf2 and HO-1 protein expression was significantly downregulated in the Nrf2 KO groups compared with the WT groups (P < 0.05). (Figure 5B, 5G-H)
We conclude that TMP acts partially via the Nrf2/HO-1 pathway to ameliorate Golgi stress, thereby alleviating endotoxin-induced ALI.
3.6. TMP attenuated inflammation and oxidative stress partially via the Nrf2/HO-1 pathway in LPS-stimulated MLE12 cells
In endotoxin-induced ALI, alveolar epithelial cells have immunomodulatory and self-renewal abilities and play a vital role in lung repair [27]. Therefore, using MLE12 alveolar epithelial cells, we evaluated the effect of TMP on LPS-stimulated ALI in vitro. To simulate a cellular model of endotoxin-induced ALI, LPS was co-cultured with MLE12 cells at various doses over 24 h, and the CCK-8 assay was used to determine cell viability. As the concentration of LPS increased, cell viability gradually decreased (Figure 6A). Cell viability decreased considerably when the LPS concentration was increased to 5 μg/ml. Therefore, 5 μg/ml was used as the LPS concentration in the experiments. MLE12 cells were treated with 5 μg/ml LPS for 24 h and pretreated with 2.5, 5, 10, 50, or 100 μg/ml TMP for 1 h. CCK-8 assays were then performed. (Figure 6B) A progressive increase in cellular viability was detected with 2.5, 5, 10, and 50 μg/ml TMP pretreatment. The highest effect was 83.74 ± 1.38% with 50 μg/ml TMP in LPS-treated cells (P < 0.05). Thus, 50 μg/ml TMP was selected for the subsequent experiments.
To explore the changes in the inflammatory level in each group, we determined IL-1β and IL-6 levels using the cell supernatant. Compared with the control group, the LPS group had considerably higher levels of IL-1β and IL-6, whereas TMP pretreatment reduced this trend (P < 0.05). (Figure 6C-6D) The levels of inflammatory factors were higher in the Nrf2 siRNA + LPS + TMP group than in the LPS + TMP group (P < 0.05), indicating that the effect of TMP on LPS-induced inflammation was partially reversed by Nrf2 knockdown.
MDA levels and SOD activity were measured in each group to determine the degree of oxidative stress damage. Compared with the LPS group, the LPS + TMP group demonstrated lower levels of oxidative stress, as shown by lower MDA levels and higher SOD activity (P < 0.05). (Figure 6E-6F) However, Nrf2 knockdown partially attenuated the antioxidant stress effects of TMP in LPS-treated cells, with increased MDA levels and reduced SOD activity compared with the LPS + TMP group (P < 0.05).
3.7. TMP attenuated LPS-stimulated ALI by alleviating Golgi stress via the Nrf2/HO-1 pathway in vitro
To further explore the mechanisms underlying the above findings, GM130, Golgin97, ATP2C1, and GOLPH3 expression and pathway-related protein Nrf2 and HO-1 expression were determined. Compared with the LPS group, TMP pretreatment in LPS-stimulated cells significantly upregulated GM130, Golgin97, and ATP2C1 protein expression and downregulated GOLPH3 protein expression (P < 0.05). (Figure 7A-7E) The Nrf2 siRNA + LPS + TMP group exhibited significantly higher levels of Golgi stress, as evidenced by decreased GM130, Golgin97, and ATP2C1 protein expression and increased GOLPH3 protein expression, compared with the LPS + TMP group (P < 0.05). TMP pretreatment upregulated Nrf2 and HO-1 protein expression, whereas Nrf2 knockdown reduced this effect (P < 0.05). (Figure 7A, 7F-7G) The above results demonstrate that TMP attenuates Golgi stress to alleviate endotoxin-induced ALI via the Nrf2/HO-1 pathway in vitro.